136 related articles for article (PubMed ID: 32503728)
1. COVID-19 pneumonia in a dual heart-kidney recipient.
Stachel MW; Gidea CG; Reyentovich A; Mehta SA; Moazami N
J Heart Lung Transplant; 2020 Jun; 39(6):612-614. PubMed ID: 32503728
[No Abstract] [Full Text] [Related]
2. Lopinavir-ritonavir in severe COVID-19.
Stower H
Nat Med; 2020 Apr; 26(4):465. PubMed ID: 32273604
[No Abstract] [Full Text] [Related]
3. A Trial of Lopinavir-Ritonavir in Covid-19.
Carmona-Bayonas A; Jimenez-Fonseca P; Castañón E
N Engl J Med; 2020 May; 382(21):e68. PubMed ID: 32369285
[No Abstract] [Full Text] [Related]
4. A Trial of Lopinavir-Ritonavir in Covid-19.
Corrao S; Natoli G; Cacopardo B
N Engl J Med; 2020 May; 382(21):e68. PubMed ID: 32369284
[No Abstract] [Full Text] [Related]
5. A Trial of Lopinavir-Ritonavir in Covid-19.
Havlichek D
N Engl J Med; 2020 May; 382(21):e68. PubMed ID: 32369283
[No Abstract] [Full Text] [Related]
6. A Trial of Lopinavir-Ritonavir in Covid-19.
Kunz KM
N Engl J Med; 2020 May; 382(21):e68. PubMed ID: 32369282
[No Abstract] [Full Text] [Related]
7. A Trial of Lopinavir-Ritonavir in Covid-19.
Dalerba P; Levin B; Thompson JL
N Engl J Med; 2020 May; 382(21):e68. PubMed ID: 32369281
[No Abstract] [Full Text] [Related]
8. Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir.
Mas Serrano M; Pérez-Sánchez JR; Portela Sánchez S; De La Casa-Fages B; Mato Jimeno V; Pérez Tamayo I; Grandas F
J Neurol Sci; 2020 Aug; 415():116944. PubMed ID: 32531579
[TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.
Kim JY
J Korean Med Sci; 2020 Feb; 35(7):e88. PubMed ID: 32080992
[No Abstract] [Full Text] [Related]
10. A Trial of Lopinavir-Ritonavir in Covid-19. Reply.
Cao B; Zhang D; Wang C
N Engl J Med; 2020 May; 382(21):e68. PubMed ID: 32369286
[No Abstract] [Full Text] [Related]
11. The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.
Lim J; Jeon S; Shin HY; Kim MJ; Seong YM; Lee WJ; Choe KW; Kang YM; Lee B; Park SJ
J Korean Med Sci; 2020 Feb; 35(7):e89. PubMed ID: 32080993
[No Abstract] [Full Text] [Related]
12. Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?
Baldelli S; Corbellino M; Clementi E; Cattaneo D; Gervasoni C
J Antimicrob Chemother; 2020 Sep; 75(9):2704-2706. PubMed ID: 32407513
[No Abstract] [Full Text] [Related]
13. In COVID-19, adding lopinavir-ritonavir to usual care did not shorten time to clinical improvement.
Yang P; Tekwani S; Martin GS
Ann Intern Med; 2020 Jun; 172(12):JC63. PubMed ID: 32539520
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19).
Schoergenhofer C; Jilma B; Stimpfl T; Karolyi M; Zoufaly A
Ann Intern Med; 2020 Oct; 173(8):670-672. PubMed ID: 32422065
[No Abstract] [Full Text] [Related]
15. Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
Cheng CY; Lee YL; Chen CP; Lin YC; Liu CE; Liao CH; Cheng SH
J Microbiol Immunol Infect; 2020 Jun; 53(3):488-492. PubMed ID: 32331982
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.
Xia T; Wang Y
Am J Transplant; 2020 Sep; 20(9):2630-2631. PubMed ID: 32400965
[No Abstract] [Full Text] [Related]
17. [Drug interaction monitoring of lopinavir/ritonavir in COVID-19 patients with cancer].
Zheng XW; Tao G; Zhang YW; Yang GN; Huang P
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):400-404. PubMed ID: 32114746
[TBL] [Abstract][Full Text] [Related]
18. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
Uzunova K; Filipova E; Pavlova V; Vekov T
Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
[TBL] [Abstract][Full Text] [Related]
19. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
Bhatnagar T; Murhekar MV; Soneja M; Gupta N; Giri S; Wig N; Gangakhedkar R
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):184-189. PubMed ID: 32362644
[TBL] [Abstract][Full Text] [Related]
20. Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
Zhu Z; Lu Z; Xu T; Chen C; Yang G; Zha T; Lu J; Xue Y
J Infect; 2020 Jul; 81(1):e21-e23. PubMed ID: 32283143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
